SCHEMBL4575321

SCHEMBL4575321

CC(C)(Oc1cccc(CCCN(Cc2ccc(-c3noc(C4CC4)n3)cc2)c2ncc(-c3ccccc3)o2)c1)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 12/20 0.47
PPARA Q07869 12/20 0.47
PPARD Q03181 7/20 0.47
TSHR P16473 3/20 0.38
ALDH1A1 P00352 2/20 0.38
LMNA P02545 2/20 0.37
HTT P42858 1/20 0.37
TUBB4A P04350 2/20 0.36
TUBB P07437 2/20 0.36
TUBA3C P0DPH7 2/20 0.36
TUBA1B P68363 2/20 0.36
TUBA4A P68366 2/20 0.36
TUBB4B P68371 2/20 0.36
TUBB3 Q13509 2/20 0.36
TUBB2A Q13885 2/20 0.36
TUBB8 Q3ZCM7 2/20 0.36
TUBA3E Q6PEY2 2/20 0.36
TUBA1A Q71U36 2/20 0.36
TUBA1C Q9BQE3 2/20 0.36
TUBB6 Q9BUF5 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4574810 0.87 PPARG (0.47) PPARGPPARAPPARDTSHRALDH1A1
SCHEMBL4575593 0.87 PPARA (0.62) PPARGPPARAPPARD
SCHEMBL4574811 0.78 PPARA (0.46) PPARGPPARAPPARDTSHRALDH1A1
SCHEMBL4575729 0.76 PPARA (0.57) PPARGPPARAPPARDCYP4F2CYP4A11
SCHEMBL4575553 0.76 PPARA (0.63) PPARGPPARAPPARDTSHRALDH1A1
SCHEMBL14277892 0.76 PPARG (0.42) PPARGPPARAPPARDTSHRALDH1A1
SCHEMBL4598247 0.74 PPARA (0.43) PPARGPPARAPPARDTSHRALDH1A1
SCHEMBL4576160 0.74 PPARA (0.44) PPARGPPARAPPARDTSHRALDH1A1
SCHEMBL4575781 0.74 PPARA (0.54) PPARGPPARAPPARDCYP4F2CYP4A11
SCHEMBL4574688 0.74 PPARA (0.54) PPARGPPARAPPARDCYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7319104-B2 hPPARs activators SMITHKLINE BEECHAM CORPORATION (US) 2008-01-15 US disclosed
US-7319104-B2 hPPARs activators SMITHKLINE BEECHAM CORPORATION (US) 2008-01-15 US disclosed
US-20050137212-A1 Hppars activators SMITHKLINE BEECHAM CORPORATION 2005-06-23 US disclosed
EP-1480957-A1 HPPARS ACTIVATORS SMITHKLINE BEECHAM CORPORATION (US) 2004-12-01 EP disclosed
WO-2003074495-A1 HPPARS ACTIVATORS SMITHKLINE BEECHAM CORPORATION (US) 2003-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137212-A1 Hppars activators PPARG, PPARA, PPARD PPARG 1/4885PPARA 2/4885PPARD 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.